Journal
ACS SENSORS
Volume 6, Issue 5, Pages 1731-1744Publisher
AMER CHEMICAL SOC
DOI: 10.1021/acssensors.1c00512
Keywords
mobile apps; telemedicine; smartphone-based sensing; point-of-care testing; colorimetric detection; electrochemical detection; open-source apps; commercial apps
Funding
- Natural Sciences and Engineering Research Council (NSERC) of Canada
- Natural Science Foundation of China [21874098, 21575098]
- Shanxi Province International Cooperation Project [201903D421053]
Ask authors/readers for more resources
Modern smartphone-based sensing devices are standalone detection platforms that can transduce signals, perform analysis through mobile apps, and display results. The development can be divided into three stages, and the mobile app-based detection system is expected to dominate point-of-care diagnosis and on-site molecular sensing in the future.
Modern smartphone-based sensing devices are generally standalone detection platforms that can transduce signals (via the built-in USB port, audio jack, or camera), perform analysis through mobile applications (apps), and display results on the screen/user interface. The advancement toward this ultimate form of on-site chemical analysis and point-of-care diagnosis is tied closely with the evolution of mobile technology. Previous reviews in the field mainly focused on the physical platforms while overlooking the role of mobile apps in such devices. There exist three general stages throughout the development: (1) early generation telemedicine, (2) mobile phone-assisted clinical diagnosis (without apps), and (3) mobile app-based sensing devices for various analytes. This review presents the key breakthroughs during each stage, recent development, remaining challenges, and future perspectives of the field. Representative examples, spanning from the pioneering point-of-care testing to the latest devices with integrated mobile apps, are classified by their sensing mechanisms. The review also discusses the scarcity of open-source apps dedicated to molecular sensing. With the introduction of more open-source and commercial apps, the mobile app-based detection system is anticipated to dominate point-of-care diagnosis and on-site molecular sensing in our opinion.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available